Opin vísindi

Fletta eftir titli tímarits "Cancer Medicine"

Fletta eftir titli tímarits "Cancer Medicine"

Röðun: Raða: Niðurstöður:

  • Dovey de la Cour, Cecilie; Guleria, Sonia; Nygård, Mari; Tryggvadottir, Laufey; Sigurdsson, Kristjan; Liaw, Kaili; Hortlund, Maria; Lagheden, Camilla; Hansen, Bo Terning; Munk, Christian; Dillner, Joakim; Kjaer, Susanne K. (Wiley, 2019-01-11)
    It is valuable to establish a population‐based prevaccination baseline distribution of human papillomavirus (HPV) types among women with high‐grade cervical intraepithelial neoplasia (CIN) grade 2 or 3 and cervical cancer in order to assess the potential ...
  • Schepsky, Alexander; Traustadóttir, Gunnhildur Ásta; Jóelsson, Jón Pétur; Ingþórsson, Sævar; Kricker, Jennifer; Bergthorsson, Jon Thor; Ásbjarnarson, Árni; Gudjonsson, Thorkell; Nupponen, Nina; Slipicevic, Ana; Lehmann, Fredrik; Gudjonsson, Thorarinn (Wiley, 2020-07-27)
    Melphalan flufenamide (hereinafter referred to as “melflufen”) is a peptide-conjugated drug currently in phase 3 trials for the treatment of relapsed or refractory multiple myeloma. Due to its lipophilic nature, it readily enters cells, where it is ...
  • Deng, Lei; Harðardóttir, Hrönn; Song, Huan; Xiao, Zhengrui; Jiang, Changchuan; Wang, Qian; Valdimarsdottir, Unnur; Cheng, Haiying; Loo, Billy W.; Lu, Donghao (Wiley, 2019-04-16)
    Lung cancer as a second primary malignancy (lung-2) is increasingly common, but its prognosis is poorly understood. This study aims to examine the overall and cancer-specific survival of patients diagnosed with lung-2 compared to lung-1. Primary lung ...